PharmaShots | Incisive News in 3 Shots

Subscribe Now

Metastatic HER2-Positive

Seattle's TUKYSA (tucatinib) Receives the US FDA's Approval for Advanced Unresectable or Metastatic HER2-Positive Breast Cancer

Seattle's TUKYSA (tucatinib) Receives the US FDA's Approval for Advanced Unresectable or Metastatic HER2-Positive Breast Cancer

April 17, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us